333
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Richter transformation in 16 of 149 Chinese patients with chronic lymphocytic leukemia

, , , , , , , & show all
Pages 1749-1756 | Received 23 Dec 2011, Accepted 02 Feb 2012, Published online: 13 Mar 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Olga Frankfurt, Shuo Ma, Leo Gordon, Jane N. Winter, Jeanne M. Horowitz, Alfred Rademaker, Bing Bing Weitner, LoAnn C. Peterson, Jessica K. Altman, Martin S. Tallman, Adam Petrich & Steven T. Rosen. (2015) Phase II study of alemtuzumab–rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomes. Leukemia & Lymphoma 56:2, pages 315-323.
Read now

Articles from other publishers (17)

Pau Abrisqueta, Ferran Nadeu, Jan Bosch-Schips, Gloria Iacoboni, Angel Serna, Alba Cabirta, Lucrecia Yáñez, Leticia Quintanilla-Martínez & Francesc Bosch. (2023) From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia. Cancer Treatment Reviews 120, pages 102619.
Crossref
Robert Briski & Justin Taylor. (2023) Treatment of Richter Transformation of Chronic Lymphocytic Leukemia in the Modern Era. Cancers 15:6, pages 1857.
Crossref
Julia Maier, André Lechel, Ralf Marienfeld, Thomas F. E. Barth, Peter Möller & Kevin Mellert. (2022) CARD9 Forms an Alternative CBM Complex in Richter Syndrome. Cancers 14:3, pages 531.
Crossref
Swetha Paduri, Nitish Singh Nandu, Thomas Brucker, Paul Roach & Mukta Pant-Purohit. (2021) Unique case of atraumatic splenic rupture in a patient with chronic lymphocytic leukaemia with Richter’s transformation. BMJ Case Reports 14:10, pages e242193.
Crossref
Anna Petrackova, Peter Turcsanyi, Tomas Papajik & Eva Kriegova. (2021) Revisiting Richter transformation in the era of novel CLL agents. Blood Reviews 49, pages 100824.
Crossref
Teng Fong Ng, Benedict Carnley, Celia Green, Dominic Spagnolo & Michael F. Leahy. (2020) The Occurrence of Richter’s Syndrome during Treatment with Obinutuzumab and Chlorambucil. Case Reports in Hematology 2020, pages 1-4.
Crossref
Andrea Lenartova, Ulla Randen, Tom Børge Johannesen & Geir Erland Tjønnfjord. (2019) Richter syndrome epidemiology in a large population based chronic lymphocytic leukemia cohort from Norway. Cancer Epidemiology 60, pages 128-133.
Crossref
John N Allan & Richard R Furman. (2018) Current trends in the management of Richter's syndrome. International Journal of Hematologic Oncology 7:4, pages IJH09.
Crossref
Kerry A. Rogers, Ying Huang, Amy S. Ruppert, Galena Salem, Deborah M. Stephens, Nyla A. Heerema, Leslie A. Andritsos, Farrukh T. Awan, John C. Byrd, Joseph M. Flynn, Kami J. Maddocks & Jeffrey A. Jones. (2018) A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor. British Journal of Haematology 180:2, pages 259-266.
Crossref
Alireza Salem, Sanam Loghavi, Joseph D Khoury, Rose Lou Marie C Agbay, Jeffrey L Jorgensen & L Jeffrey Medeiros. (2017) Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature. Histopathology 70:5, pages 821-831.
Crossref
Rose Lou Marie C. Agbay, Nitin Jain, Sanam Loghavi, L. Jeffrey Medeiros & Joseph D. Khoury. (2016) Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. American Journal of Hematology 91:10, pages 1036-1043.
Crossref
Rose Lou Marie C. Agbay, Sanam Loghavi, L. Jeffrey Medeiros & Joseph D. Khoury. (2016) High-grade Transformation of Low-grade B-cell Lymphoma. American Journal of Surgical Pathology 40:1, pages e1-e16.
Crossref
Renata Woroniecka, Grzegorz Rymkiewicz, Beata Grygalewicz, Katarzyna Błachnio, Jolanta Rygier, Małgorzata Jarmuż-Szymczak, Błażej Ratajczak & Barbara Pieńkowska-Grela. (2015) Cytogenetic and Flow Cytometry Evaluation of Richter Syndrome Reveals MYC, CDKN2A, IGH Alterations With Loss of CD52, CD62L and Increase of CD71 Antigen Expression as the Most Frequent Recurrent Abnormalities. American Journal of Clinical Pathology 143:1, pages 25-35.
Crossref
Sameer A. Parikh & Tait D. Shanafelt. (2014) Risk Factors for Richter Syndrome in Chronic Lymphocytic Leukemia. Current Hematologic Malignancy Reports 9:3, pages 294-299.
Crossref
Sameer A. Parikh, Neil E. Kay & Tait D. Shanafelt. (2014) How we treat Richter syndrome. Blood 123:11, pages 1647-1657.
Crossref
M. Fiegl, R. Stauder, M. Steurer, M. Mian, G. Hopfinger, Y. Brychtova, C. Skrabs, A. Zabernigg, F. Schmid, F. Haslbaur, G. Winder, A. Walder, A. Lang, D. Voskova, R. Greil, J. Mayer & G. Gastl. (2013) Alemtuzumab in chronic lymphocytic leukemia: final results of a large observational multicenter study in mostly pretreated patients. Annals of Hematology 93:2, pages 267-277.
Crossref
Sameer A. Parikh, Kari G. Rabe, Timothy G. Call, Clive S. Zent, Thomas M. Habermann, Wei Ding, Jose F. Leis, Susan M. Schwager, Curtis A. Hanson, William R. Macon, Neil E. Kay, Susan L. Slager & Tait D. Shanafelt. (2013) Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients. British Journal of Haematology 162:6, pages 774-782.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.